Total Funding
8
20
Total FundingVenture - Series Unknown raised
Growth Score 8 in past quarter
-6 pts
Heat Score 20 in past quarter
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
337230
Exogenesis Corporation is engaged in developing and processing implantable vascular stents, orthopedic devices and other related products.
- Simon Luhr: Investor
Steve Blinn: ConsultantPast Role: Summit Technology, Executive Vice President
About the Company
Exogenesis Corporation engages in developing and processing implantable vascular stents, orthopedic devices, and other medical products utilizing its gas cluster ion beam technology. It offers ClusterCoat Processing System, a room temperature method for modifying the physical and chemical properties of outermost atomic layers of surface while
leaving the underlying bulk of the unaffected material. The company was founded in 2005 and is based in Billerica, Massachusetts.

